- Home
- EBON vs ANTX Comparison
EBON vs ANTX Comparison
Compare EBON & ANTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EBON
- ANTX
- Stock Information
- Founded
- EBON 2018
- ANTX 2017
- Country
- EBON China
- ANTX United States
- Employees
- EBON N/A
- ANTX N/A
- Industry
- EBON Semiconductors
- ANTX Biotechnology: Pharmaceutical Preparations
- Sector
- EBON Technology
- ANTX Health Care
- Exchange
- EBON Nasdaq
- ANTX Nasdaq
- Market Cap
- EBON 39.9M
- ANTX 37.6M
- IPO Year
- EBON 2020
- ANTX 2022
- Fundamental
- Price
- EBON $6.33
- ANTX $1.27
- Analyst Decision
- EBON
- ANTX Hold
- Analyst Count
- EBON 0
- ANTX 5
- Target Price
- EBON N/A
- ANTX $3.50
- AVG Volume (30 Days)
- EBON 38.8K
- ANTX 143.7K
- Earning Date
- EBON 08-23-2024
- ANTX 11-13-2024
- Dividend Yield
- EBON N/A
- ANTX N/A
- EPS Growth
- EBON N/A
- ANTX N/A
- EPS
- EBON N/A
- ANTX N/A
- Revenue
- EBON $3,591,648.00
- ANTX N/A
- Revenue This Year
- EBON N/A
- ANTX N/A
- Revenue Next Year
- EBON N/A
- ANTX N/A
- P/E Ratio
- EBON N/A
- ANTX N/A
- Revenue Growth
- EBON N/A
- ANTX N/A
- 52 Week Low
- EBON $5.34
- ANTX $0.87
- 52 Week High
- EBON $14.19
- ANTX $21.40
- Technical
- Relative Strength Index (RSI)
- EBON 47.11
- ANTX 44.51
- Support Level
- EBON $5.62
- ANTX $1.34
- Resistance Level
- EBON $6.52
- ANTX $1.28
- Average True Range (ATR)
- EBON 0.46
- ANTX 0.06
- MACD
- EBON 0.02
- ANTX -0.02
- Stochastic Oscillator
- EBON 52.01
- ANTX 21.74
About EBON Ebang International Holdings Inc.
Ebang International Holdings Inc is a blockchain technology and Fintech company, that has ASIC chip design capability. Its business is ASIC chip design and Telecommunication. It operates in a single segment selling bitcoin mining machines and related accessories, telecommunication products, providing cryptocurrency exchange services, management and maintenance services, and cross-border payment and foreign exchange services. Its geographic regions are Mainland China, Australia, and Other countries and regions.
About ANTX AN2 Therapeutics Inc.
AN2 Therapeutics Inc is a clinical-stage biopharmaceutical company developing treatments for rare, chronic, and serious infectious diseases with high unmet needs. The initial product candidate is epetraborole, a once-daily oral treatment for patients with chronic non-tuberculous mycobacterial, or NTM, lung disease.